# Prepivotal Omnipod Horizon™ Automated Glucose Control System

> **NCT04176731** · NA · COMPLETED · sponsor: **Insulet Corporation** · enrollment: 36 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DEVICE:** Omnipod Horizon™ Automated Glucose Control System

## Key facts

- **NCT ID:** NCT04176731
- **Lead sponsor:** Insulet Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-15
- **Primary completion:** 2020-01-31
- **Final completion:** 2020-01-31
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2023-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04176731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04176731, "Prepivotal Omnipod Horizon™ Automated Glucose Control System". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04176731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*